ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » North Carolina » Internal Medicine

Top Internal Medicine Prescribers in North Carolina

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
DANIEL CROCKER M.D.

Internal Medicine

56,804

$3.48M

1874
1466 are 65+

11%
patients receiving schedule two controlled substances

Avg: 5%

14%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 26%

$61
Average prescription price

Avg: $58

IMRAN HAQUE M.D.

Internal Medicine

50,569

$3.32M

1204
786 are 65+

18%
patients receiving schedule two controlled substances

Avg: 5%

16%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 26%

$66
Average prescription price

Avg: $58

PANKAJ VYAS M.D.

Internal Medicine

45,417

$2.25M

1480
995 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

17%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 26%

$49
Average prescription price

Avg: $58

ENRIQUE VARELA MD

Internal Medicine

44,541

$2.76M

771
680 are 65+

21%
patients receiving schedule two controlled substances

Avg: 5%

23%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$62
Average prescription price

Avg: $58

LAKSHMAN RAO MD

Internal Medicine

40,642

$2.25M

1028
773 are 65+

13%
patients receiving schedule two controlled substances

Avg: 5%

16%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 26%

$55
Average prescription price

Avg: $58

SEMAAN EL-KHOURY MD

Internal Medicine

38,533

$2.22M

1247
865 are 65+

10%
patients receiving schedule two controlled substances

Avg: 5%

18%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 26%

$58
Average prescription price

Avg: $58

MARY RUDYK M.D.

Internal Medicine

37,926

$2.05M

1324
1197 are 65+

8%
patients receiving schedule two controlled substances

Avg: 5%

7%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 26%

$54
Average prescription price

Avg: $58

DHRUV VYAS M.D.

Internal Medicine

35,929

$1.58M

1259
983 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

19%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$44
Average prescription price

Avg: $58

DOUGLAS KELLING M.D.

Internal Medicine

34,799

$2.53M

1554
1177 are 65+

2%
patients receiving schedule two controlled substances

Avg: 5%

10%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 26%

$73
Average prescription price

Avg: $58

RICHARD ORR MD

Internal Medicine

34,585

$1.71M

1063
967 are 65+

3%
patients receiving schedule two controlled substances

Avg: 5%

5%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$50
Average prescription price

Avg: $58

XAJE HASANAJ M.D.

Internal Medicine

34,193

$1.88M

1211
869 are 65+

13%
patients receiving schedule two controlled substances

Avg: 5%

18%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$55
Average prescription price

Avg: $58

TERRY ARNOLD MD

Internal Medicine

32,525

$2.05M

1033
901 are 65+

11%
patients receiving schedule two controlled substances

Avg: 5%

17%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 26%

$63
Average prescription price

Avg: $58

ASHISH SHAH M.D.

Internal Medicine

32,323

$1.48M

1142
836 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

20%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$46
Average prescription price

Avg: $58

GARY ROPER GARY ROPER

Internal Medicine

31,381

$2.03M

785
591 are 65+

14%
patients receiving schedule two controlled substances

Avg: 5%

11%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 26%

$65
Average prescription price

Avg: $58

TEIGHA RANDOLPH MD

Internal Medicine

30,539

$1.57M

874
735 are 65+

3%
patients receiving schedule two controlled substances

Avg: 5%

10%
patients receiving schedule three controlled substances

Avg: 9%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 26%

$51
Average prescription price

Avg: $58

STEVEN HAMSTEAD M.D.

Internal Medicine

30,500

$1.37M

980
789 are 65+

9%
patients receiving schedule two controlled substances

Avg: 5%

13%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$45
Average prescription price

Avg: $58

BYRON HOFFMAN MD

Internal Medicine

29,742

$1.65M

917
808 are 65+

11%
patients receiving schedule two controlled substances

Avg: 5%

12%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 26%

$56
Average prescription price

Avg: $58

VISWANATHA REDDY M.D.

Internal Medicine

28,357

$1.4M

897
584 are 65+

8%
patients receiving schedule two controlled substances

Avg: 5%

23%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 26%

$49
Average prescription price

Avg: $58

CLAUDE WHITWORTH M.D.

Internal Medicine

27,669

$1.38M

800
663 are 65+

9%
patients receiving schedule two controlled substances

Avg: 5%

25%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$50
Average prescription price

Avg: $58

GEOFFREY BURBRIDGE M.D.

Internal Medicine

27,185

$1.46M

764
625 are 65+

11%
patients receiving schedule two controlled substances

Avg: 5%

15%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 26%

$54
Average prescription price

Avg: $58

JAMES LONG M.D.

Internal Medicine

26,820

$1.39M

672
585 are 65+

11%
patients receiving schedule two controlled substances

Avg: 5%

15%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$52
Average prescription price

Avg: $58

IBIKUNLE OJEBUOBOH M.D.

Internal Medicine

26,440

$2.13M

704
390 are 65+

19%
patients receiving schedule two controlled substances

Avg: 5%

22%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 26%

$81
Average prescription price

Avg: $58

MICHAEL JAMES M.D.

Internal Medicine

26,217

$1.84M

701
630 are 65+

12%
patients receiving schedule two controlled substances

Avg: 5%

13%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 26%

$70
Average prescription price

Avg: $58

VINCENT KEIPPER MD

Internal Medicine

26,143

$1.56M

603
499 are 65+

12%
patients receiving schedule two controlled substances

Avg: 5%

19%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 26%

$60
Average prescription price

Avg: $58

CARLA PENCE MD

Internal Medicine

26,010

$1.11M

869
712 are 65+

10%
patients receiving schedule two controlled substances

Avg: 5%

21%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 26%

$43
Average prescription price

Avg: $58

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank